How ExciIQ helps

For the compounding pharmacist

You’re often the last stop. The patient who reacts to every commercial version of a drug lands at your counter. The referral note says “sensitive to fillers, please compound.”

Which fillers? Nobody upstream could say. ExciIQ turns that guess into a workup.

Sort the patient’s medication history into tolerated Friends and reaction-associated Foes. ExciIQ calls this workup Friend or Foe.

ExciIQ lists the suspect excipients that appear only in the Foes. When a suspect appears in every Foe, it is flagged as a Top Suspect.

Check each suspect against the full regimen, not one label at a time. ExciIQ shows cumulative daily intake per excipient across everything the patient takes.

ExciIQ checks commercial equivalents against the trigger and gives each one of three honest verdicts: safe, contains the avoided excipient, or uncertain. A verdict of safe means the product provably avoids the trigger. Uncertain is never dressed up as safe.

You compound with a defensible rationale instead of a hunch. You document the ingredients you excluded, and why.

Professional use only — not for patient diagnosis or treatment decisions.

For the retail / community pharmacist

The refill matches in the system: same drug, same strength. But your wholesaler switched manufacturers. Three weeks later the patient is back describing a rash.

The active ingredient is unchanged. The inactive ingredients are a different story, and until now an invisible one.

ExciIQ lets you compare the products in question by manufacturer and by strength. The same drug’s excipients can differ across both.

Search by name or NDC, or identify the pill in the vial by its imprint. Open each product’s structured FDA label and see its inactive ingredients plainly.

For patients managing celiac disease, lactose intolerance, or dye sensitivities, look up an excipient once. See which products contain it and which equivalents provably avoid it.

The question that used to cost an afternoon of label archaeology finally has somewhere to go.

Professional use only — not for patient diagnosis or treatment decisions.

For the allergist, immunologist, or physician

The chart says “multiple drug allergies.” The patient says the reactions never quite made sense: different drugs, different classes, the same rash.

When the actives don’t explain the pattern, the excipients might. The same dye, binder, or preservative can thread through otherwise unrelated products. It can enter or leave the picture with a manufacturer switch the patient never knew about.

ExciIQ lets you work that hypothesis with the real products in hand. Pull each product the patient received by name, NDC, or pill imprint. See its inactive ingredients as labeled, specific to manufacturer and strength.

Sort what was tolerated from what drew a reaction. ExciIQ shows the candidate excipients unique to the reaction-associated products. That is a shortlist to carry into your workup, not a verdict.

Then work that shortlist forward. Look up any excipient to see which products contain it. Find equivalents that provably avoid it for the note back to the prescribing team and the pharmacy.

Every record carries provenance. When a label disagrees with itself, you see it. A workup is only as good as the ingredient list under it.

Professional use only — not for patient diagnosis or treatment decisions.

For the hospital pharmacist

The formulary didn’t change. The supplier did.

Shortages and contract switches swap one manufacturer’s product for another’s. The inactive ingredients swap silently with them.

For most patients it never matters. For the patient with a documented sensitivity to lactose, a dye, or a preservative, “same drug, same strength” isn’t the whole answer. A check aimed at active ingredients won’t see it.

ExciIQ gives you the product-level view. Compare products at exact manufacturer and strength. Confirm what the newly stocked NDC actually carries.

Then answer the floor’s question with the label record in front of you.

When a substitution needs to avoid a specific excipient, ExciIQ gives three honest verdicts: safe, contains the avoided excipient, or uncertain. Uncertain is never dressed up as safe.

And because ExciIQ holds no patient data by architecture, adding it doesn’t add a patient-data footprint.

Professional use only — not for patient diagnosis or treatment decisions.

Veterinary

The patient who can’t tell you it’s the excipient.

Animals metabolize differently. The excipient that’s harmless in your hand can be the problem in the exam room. Xylitol, safe in a human tablet, is dangerous to dogs.

Veterinary practice lives with this every day. Human-labeled products are dispensed under extra-label use.

Species sensitivities appear that the label never anticipated. Compounding requests are built around what an animal can’t tolerate.

ExciIQ covers FDA’s human labeling today, prescription and OTC, at product-and-strength precision. That is the label set extra-label dispensing draws on. We plan to load FDA’s animal labeling in Q4 2026.

Look up any excipient and see which products carry it. Check a human-labeled product’s inactive list before it goes anywhere near a patient with four legs. Find products that provably avoid what the species, or the individual animal, can’t have.

The veterinary side of the counter gets the same honest verdicts as everyone else: safe, contains the avoided excipient, or uncertain.

Professional use only — not for patient diagnosis or treatment decisions.

For the pharmacy owner

The excipient detective work already happens in your pharmacy. It lives in individual pharmacists’ heads and walks out the door with turnover.

ExciIQ gives the whole team one consistent way to run an excipient workup. Whoever is on shift gets the same honest verdicts, the same provenance, and the same defensible rationale. Saved workups survive staff handoffs and the patient’s next visit.

And because ExciIQ holds no patient data by architecture, bringing it into the pharmacy adds capability without adding a data liability.

Professional use only — not for patient diagnosis or treatment decisions.